Influencing Factors and Predictors of Early Response in Schizophrenia Patients Receiving the Paliperidone Extended-Release Tablets (Paliperidone ER)

OBJECTIVE: Paliperidone extended-release tablet (paliperidone ER) is a new oral psychotropic agent developed for schizophrenia treatment. There have been some studies about paliperidone's good efficacy and tolerability. Clinicians appear to change the antipsychotic medication to paliperidone ER...

Descripción completa

Detalles Bibliográficos
Autores principales: Jung, Seung-Ho, Yoon, Jin-Sang, Ahn, Yong-Min, Kim, Yong-Sik, Kim, Chul-Eung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Neuropsychiatric Association 2013
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3902160/
https://www.ncbi.nlm.nih.gov/pubmed/24474991
http://dx.doi.org/10.4306/pi.2013.10.4.407

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3902160/
https://www.ncbi.nlm.nih.gov/pubmed/24474991
http://dx.doi.org/10.4306/pi.2013.10.4.407

Ejemplares similares